ODTX
Odyssey Therapeutics, Inc.
20.99
+0.99 (+4.95%)
52w low 15.10
29.05 high
42.2% of range
Financial Analysis
| Ratio | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 | Trend |
|---|---|---|---|---|---|---|---|
| Profitability | |||||||
| Operating Margin | -- | -36,749.5% | -- | -- | -- | -- | |
| EBITDA Margin | -- | -34,675.8% | -- | -- | -- | -- | |
| Net Margin | -- | -35,820.2% | -- | -- | -- | -- | |
| FCF Margin | -- | -31,621.2% | -- | -- | -- | -- | |
| Returns | |||||||
| Return on Equity | -- | -- | 6.9% | 7.3% | -12.5% | -14.1% | |
| Return on Assets | -- | -- | -12.4% | -16.7% | -10.9% | -12.1% | |
| Return on Inv Capital | -- | -- | 6.9% | 7.3% | -12.5% | -14.1% | |
| Liquidity | |||||||
| Current Ratio | -- | -- | 7.20x | 8.33x | 11.36x | 12.94x | |
| Quick Ratio | -- | -- | 7.20x | 8.33x | 11.36x | 12.94x | |
| Cash Ratio | -- | -- | 1.57x | 1.61x | 2.90x | 3.09x | |
| Leverage | |||||||
| Debt / Equity | -- | -- | -0.06x | -0.05x | 0.06x | 0.06x | |
| Interest Coverage | -- | -35517.00x | -2878.67x | -3818.90x | -2638.80x | -4416.50x | |
| Equity Multiplier | -- | -- | -0.55x | -0.44x | 1.15x | 1.17x | |
| Efficiency | |||||||
| Asset Turnover | -- | -- | 0.00x | 0.00x | 0.00x | 0.00x | |
| Effective Tax Rate | -- | 0.2% | 3.0% | -0.2% | 0.0% | -0.1% | |
| Op CF / Net Income | -- | 0.88x | 0.76x | 1.07x | 0.65x | 0.78x | |
| Investment | |||||||
| Capex / Revenue | -- | 48.5% | -- | -- | -- | -- | |
| R&D / Revenue | -- | 26,590.9% | -- | -- | -- | -- | |
| SG&A / Revenue | -- | 10,258.6% | -- | -- | -- | -- | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--